West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)
Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%
West Pharmaceutical Services profit margin
Profit margin (net margin) is net income as a percentage of revenue.
West Pharmaceutical Services's profit margin for the twelve months ending Sep 30, 2026 was 18.8%. For fiscal 2025 it was 16.1%, against 17.0% the year before. The highest annual figure on record is 23.4% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16.1% | −1.0 |
| FY2024 | Dec 31, 2024 | 17.0% | −3.1 |
| FY2023 | Dec 31, 2023 | 20.1% | −0.2 |
| FY2022 | Dec 31, 2022 | 20.3% | −3.1 |
| FY2021 | Dec 31, 2021 | 23.4% | +7.2 |
| FY2020 | Dec 31, 2020 | 16.1% | +3.0 |
| FY2019 | Dec 31, 2019 | 13.1% | +1.1 |
| FY2018 | Dec 31, 2018 | 12.0% | +6.1 |
| FY2010 | Dec 31, 2010 | 5.9% | −1.0 |
| FY2009 | Dec 31, 2009 | 6.9% | −1.3 |
| FY2008 | Dec 31, 2008 | 8.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 24.5% | +7.1 |
| Q2 FY2026 | Jun 30, 2026 | 17.7% | +0.5 |
| Q1 FY2026 | Mar 31, 2026 | 16.4% | +3.6 |
| Q4 FY2025 | Dec 31, 2025 | 16.4% | −1.0 |
| Q3 FY2025 | Sep 30, 2025 | 17.4% | −0.8 |
| Q2 FY2025 | Jun 30, 2025 | 17.2% | +1.3 |
| Q1 FY2025 | Mar 31, 2025 | 12.9% | −3.7 |
| Q4 FY2024 | Dec 31, 2024 | 17.4% | −1.3 |
| Q3 FY2024 | Sep 30, 2024 | 18.2% | −3.4 |
| Q2 FY2024 | Jun 30, 2024 | 15.9% | −4.7 |
| Q1 FY2024 | Mar 31, 2024 | 16.6% | −3.0 |
| Q4 FY2023 | Dec 31, 2023 | 18.7% | +4.2 |
| Q3 FY2023 | Sep 30, 2023 | 21.6% | +4.0 |
| Q2 FY2023 | Jun 30, 2023 | 20.6% | −3.9 |
| Q1 FY2023 | Mar 31, 2023 | 19.5% | −4.6 |
| Q4 FY2022 | Dec 31, 2022 | 14.5% | −5.7 |
| Q3 FY2022 | Sep 30, 2022 | 17.6% | −7.3 |
| Q2 FY2022 | Jun 30, 2022 | 24.4% | −1.4 |
| Q1 FY2022 | Mar 31, 2022 | 24.1% | +1.6 |
| Q4 FY2021 | Dec 31, 2021 | 20.2% | +3.3 |
| Q3 FY2021 | Sep 30, 2021 | 24.9% | +9.8 |
| Q2 FY2021 | Jun 30, 2021 | 25.9% | +8.6 |
| Q1 FY2021 | Mar 31, 2021 | 22.5% | +7.4 |
| Q4 FY2020 | Dec 31, 2020 | 17.0% | +3.4 |
| Q3 FY2020 | Sep 30, 2020 | 15.0% | +2.7 |
| Q2 FY2020 | Jun 30, 2020 | 17.3% | +3.2 |
| Q1 FY2020 | Mar 31, 2020 | 15.1% | +2.6 |
| Q4 FY2019 | Dec 31, 2019 | 13.6% | – |
| Q3 FY2019 | Sep 30, 2019 | 12.3% | – |
| Q2 FY2019 | Jun 30, 2019 | 14.1% | – |
| Q1 FY2019 | Mar 31, 2019 | 12.5% | – |
See a number that looks wrong?